Client News

NanoViricides to Present COVID-19 Drug Update at The LD 500 Virtual Conference

SHELTON, CT / ACCESSWIRE / September 2, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 8:20 AM PDT / 11:20 AM EDT. Anil R. Diwan, PhD, President and Executive Chairman of […]

LifeQuest to Present at The LD 500 Virtual Conference

LOS ANGELES, CA / ACCESSWIRE / August 20, 2020 / LifeQuest World Corp (OTCQB:LQWC), today announced that it will be presenting at the LD 500 Virtual Conference on Wednesday, September 2nd at 1:00 PM PDT / 4:00 PM EDT. Max Khan, president & chief executive officer of LifeQuest, will be presenting to a live audience. LifeQuest’s mission is to become a global leader in low-cost, low-maintenance, eco-friendly, decentralized wastewater treatment. Biopipe, […]

Applied UV Announces Pricing of $5 Million Initial Public Offering

MOUNT VERNON, NY / ACCESSWIRE / August 31, 2020 / Applied UV, Inc. (NASDAQ:AUVI) (“Applied UV” or the “Company”), an infection prevention technology company that applies the power of narrow-range ultra violet light (“UVC”) to destroy pathogens safely, thoroughly, and automatically, today announced the pricing of its initial public offering of 1,000,000 shares of its common […]

Lifequest Subsidiary Biopipe Global Signs Memorandum of Understanding with the Water Development Commission of Ethiopia for the Introduction of its Onsite 100% Sludge Free Biological Sewage Wastewater Treatment System

Ridgefield Park, New Jersey, July 22, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — LIFEQUEST WORLD CORP (LQWC) subsidiary Biopipe Global, which developed the world’s only highly scalable onsite sludge and chemical free sewage wastewater treatment technology, has signed a Memorandum of Understanding (MoU) with the Water Development Commission of the Ministry of Water, Irrigation and Energy of […]

Know Labs Enters into Research Agreement with Mayo Clinic

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, announced today that it has entered into a Research Agreement with Mayo Clinic to test and validate its patented Bio-RFID™ platform technology. Know Labs plans to first deploy its Bio-RFID platform in its wearable UBAND™ as a non-invasive Continuous Glucose Monitor (CGM). Phil Bosua, […]

NanoViricides Closes On $11.5 Million Underwritten Public Offering of Common Stock

SHELTON, CT / ACCESSWIRE / July 13, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today announced that it has completed an underwritten public offering (the “Offering”) with gross proceeds of $11.5 million before deducting underwriting discounts and other […]

NanoViricides Prices $10.0 Million Underwritten Public Offering of Common Stock

ACCESSWIRE•July 9, 2020 SHELTON, CT / ACCESSWIRE / July 9, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform (the “Company”), today announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $10.0 […]

NanoViricides News

Safety and Tolerability of Anti-Coronavirus Drug Candidates Observed in an Animal Model Further Advances NanoViricides’ SARS-CoV-2 Therapeutics Program SHELTON, CT / ACCESSWIRE / July 8, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announced today that excellent safety and tolerability […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.